Unknown molecular target mediating membrane energetics disruption – Mycobacterium tuberculosis

The Unknown molecular target mediating membrane energetics disruption in Mycobacterium tuberculosis refers to the physiological mechanism or unidentified molecular entity responsible for maintaining the bacterial proton motive force (PMF) and membrane potential. This target is primarily associated with the mechanism of action of pyrazinamide (PZA), a cornerstone of first-line tuberculosis therapy. PZA is a prodrug converted by the bacterial enzyme pyrazinamidase into pyrazinoic acid (POA), which accumulates in the cytoplasm and disrupts the PMF, particularly under acidic conditions. This disruption leads to cytoplasmic acidification, inhibition of membrane transport, and depletion of ATP, which is lethal to non-replicating persister bacilli. While specific proteins such as RpsA (ribosomal protein S1) and PanD (aspartate decarboxylase) have been proposed as binding partners for POA, the unknown designation reflects the ongoing debate regarding whether these proteins or the membrane itself is the primary site of action for the observed bioenergetic collapse. Other drugs, such as clofazimine and verapamil, also interact with this target by destabilizing the membrane or interfering with respiratory chain components, further highlighting its importance in anti-tuberculosis drug development.

Other names

Membrane energetics disruptionProton motive force disruptionPOA targetPyrazinamide target (unknown)

Disruption of the proton motive force (PMF) and membrane potential, leading to acidification of the cytoplasm and inhibition of membrane transport.